Showing results (211-220 of 560) with videos related to

Sort By:
Pageof 56
The Oncologist|March 9, 2012
Time course and predictors for cancer-related fatigue in a series of oropharyngeal cancer patients treated with chemoradiation therapyDaniel E Spratt, Mayuko Sakae, Nadeem Riaz, et al.
Primary Care Diabetes|November 6, 2017
Medicare utilization, screening, and costs among participants in the Southeastern Diabetes Initiative: A population-based evaluationCourtney H Van Houtven, Melissa A Greiner, Brooke Heidenfelder, et al.
Bioscience Reports|September 16, 2022
Redefining the catalytic HECT domain boundaries for the HECT E3 ubiquitin ligase familyEmma I Kane, Steven A Beasley, Johanna M Schafer, et al.
Molecular Imaging and Biology|May 24, 2017
Repeatability of [68Ga]DKFZ11-PSMA PET Scans for Detecting Prostate-specific Membrane Antigen-positive Prostate CancerJoseph R Osborne, Teja M Kalidindi, Blesida J Punzalan, et al.
European Urology|October 14, 2014
The natural history and predictors of outcome following biochemical relapse in the dose escalation era for prostate cancer patients undergoing definitive external beam radiotherapyZachary S Zumsteg, Daniel E Spratt, Paul B Romesser, et al.
Technical Innovations & Patient Support in Radiation Oncology|May 7, 2026
Patient-reported distress and anxiety during cone-beam CT imaging sessions with increased gantry rotation speedsAtefeh Rezaei, Alex T Price, Theodore H Arsenault, et al.
The FEBS Journal|February 6, 2019
A subset of calcium-binding S100 proteins show preferential heterodimerizationDonald E Spratt, Kathryn R Barber, Nicole M Marlatt, et al.
World Journal of Urology|October 4, 2023
Association of PSA kinetics after testosterone recovery with subsequent recurrence: secondary analysis of a phase III randomized controlled trialSoumyajit Roy, Amar U Kishan, Scott C Morgan, et al.
Cell Reports|August 4, 2021
Paradoxical hyperexcitability from NaV1.2 sodium channel loss in neocortical pyramidal cellsPerry W E Spratt, Ryan P D Alexander, Roy Ben-Shalom, et al.
Oral Oncology|July 22, 2014
The relative prognostic utility of standardized uptake value, gross tumor volume, and metabolic tumor volume in oropharyngeal cancer patients treated with platinum based concurrent chemoradiation with a pre-treatment [(18)F] fluorodeoxyglucose positron emission tomography scanPaul B Romesser, Remy Lim, Daniel E Spratt, et al.
Pageof 56